Trending...
- Yoga Retreats, Ecstatic Dance & Spiritual App launched
- Janie's Art Journals Celebrates Women's History Month
- Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
UTRECHT, Netherlands, May 30, 2024 ~ FutureBridge, a leading techno-commercial consulting and advisory company, is gearing up to engage with industry leaders at two highly anticipated conferences. The company's life sciences practice, which provides strategic guidance to global companies in the pharmaceutical, biotech, medtech, diagnostics, and animal health sectors, will be participating in the 2024 ASCO (American Society of Clinical Oncology) Annual Meeting and the BIO International Conference 2024.
According to Shivali Jasrotia, Senior Consultant at FutureBridge, the company is excited to share their expertise on the future of medicines, healthcare solutions, disruptive trends, emerging technologies, and therapeutic platforms at these conferences. They also aim to strengthen relationships with existing clients and establish new collaborations with industry experts from academia, patient advocacy groups, innovators, and key opinion leaders.
The ASCO 2024 Annual Meeting will take place in Chicago from May 31st to June 4th and is expected to attract over 40,000 members. This conference will showcase breakthroughs in oncology including advancements in immune checkpoint blockade optimization, lung cancer treatment, breast cancer diagnostics, early melanoma intervention, and early-stage rectal cancer management. Major pharmaceutical companies will also present outcomes and updates of their clinical programs.
More on illi News
"We will be closely following key clinical trial abstracts presented by companies like AstraZeneca,Janssen,and Bristol Myers Squibb at ASCO 2024. Our team is passionate about these topics and we will be providing a short but insightful analysis for our industry colleagues who are unable to attend this event. We are happy to share this analysis with anyone who requests it," said Jasrotia.
The BIO International Conference 2024 will take place in San Diego from June 3rd to June 6th and is considered the premier biotech networking event with over 20,000 industry leaders expected to attend. This year's participants include top biopharmaceutical companies such as Amgen, Pfizer, Novartis, Merck, and Gilead Sciences. The conference aims to facilitate the discovery of new opportunities and the development of partnerships within the biotech and pharmaceutical sectors.
FutureBridge believes that their expertise in tracking early signals in the industry and their implications sets them apart. They offer solutions for the volatile, uncertain, complex, and ambiguous (VUCA) world through their advisory and consulting services. "We believe that business uncertainties from rising failure risks, declining R&D productivity, high unmet clinical needs, and margin pressures can be overcome with a culture of collective and open innovation. Conferences like ASCO, ESMO, and BIO International bridge gaps in scientific data, uniting the competition, world, and technology for a better future," said Manoj Jiandani, Practice Area Head at FutureBridge.
More on illi News
Jiandani also encourages industry leaders to meet with FutureBridge at ASCO 2024 or BIO International this year to learn how their evidence-based consulting solutions can drive results for pharma leaders and address their most critical business challenges. Interested parties can schedule a meeting or reach out to FutureBridge via email at for more information.
In conclusion, FutureBridge's participation in these conferences highlights their commitment to staying at the forefront of industry developments and providing valuable insights to their clients. With a focus on innovation and collaboration, they aim to help businesses navigate the ever-changing landscape of the life sciences industry.
According to Shivali Jasrotia, Senior Consultant at FutureBridge, the company is excited to share their expertise on the future of medicines, healthcare solutions, disruptive trends, emerging technologies, and therapeutic platforms at these conferences. They also aim to strengthen relationships with existing clients and establish new collaborations with industry experts from academia, patient advocacy groups, innovators, and key opinion leaders.
The ASCO 2024 Annual Meeting will take place in Chicago from May 31st to June 4th and is expected to attract over 40,000 members. This conference will showcase breakthroughs in oncology including advancements in immune checkpoint blockade optimization, lung cancer treatment, breast cancer diagnostics, early melanoma intervention, and early-stage rectal cancer management. Major pharmaceutical companies will also present outcomes and updates of their clinical programs.
More on illi News
- $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
- Jones Software Corp Expands AI Skilling Through Microsoft Commercial Marketplace with Global Deliver
- ASI Hosts 2026 Executive Business Summit for Global Partner Community
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
"We will be closely following key clinical trial abstracts presented by companies like AstraZeneca,Janssen,and Bristol Myers Squibb at ASCO 2024. Our team is passionate about these topics and we will be providing a short but insightful analysis for our industry colleagues who are unable to attend this event. We are happy to share this analysis with anyone who requests it," said Jasrotia.
The BIO International Conference 2024 will take place in San Diego from June 3rd to June 6th and is considered the premier biotech networking event with over 20,000 industry leaders expected to attend. This year's participants include top biopharmaceutical companies such as Amgen, Pfizer, Novartis, Merck, and Gilead Sciences. The conference aims to facilitate the discovery of new opportunities and the development of partnerships within the biotech and pharmaceutical sectors.
FutureBridge believes that their expertise in tracking early signals in the industry and their implications sets them apart. They offer solutions for the volatile, uncertain, complex, and ambiguous (VUCA) world through their advisory and consulting services. "We believe that business uncertainties from rising failure risks, declining R&D productivity, high unmet clinical needs, and margin pressures can be overcome with a culture of collective and open innovation. Conferences like ASCO, ESMO, and BIO International bridge gaps in scientific data, uniting the competition, world, and technology for a better future," said Manoj Jiandani, Practice Area Head at FutureBridge.
More on illi News
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
- Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
Jiandani also encourages industry leaders to meet with FutureBridge at ASCO 2024 or BIO International this year to learn how their evidence-based consulting solutions can drive results for pharma leaders and address their most critical business challenges. Interested parties can schedule a meeting or reach out to FutureBridge via email at for more information.
In conclusion, FutureBridge's participation in these conferences highlights their commitment to staying at the forefront of industry developments and providing valuable insights to their clients. With a focus on innovation and collaboration, they aim to help businesses navigate the ever-changing landscape of the life sciences industry.
Filed Under: Business
0 Comments
Latest on illi News
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
- Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
- The Friendly Music Community Unveils The Friendly Listening Room with Premier Performance by Acclai
- Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
- From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
- Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
- New Portable Toilet Drain Adapter Eliminates Manual Waste Tank Emptying
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- Night Shade Introduces Smart Privacy Protection for Modern Devices
- Innovative Ear Muff Hat Combines Warmth and Convenience in One Winter Accessory
- Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
- New Repositionable Handheld Easel Offers Artists Greater Freedom and Flexibility
- Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
- 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
- Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
- Greater Englewood Chamber of Commerce to Host Member Meeting on March 11, 2026
- Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
- Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
- Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final